NCT04253119 - ART First-line Treatment Durability in Russia | Biotech Hunter

Enrollment

536

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

HIV-1-infection

Interventions

DRUG

Antiretroviral/Anti HIV

NNRTI plus two NRTIs or PI boosted by ritonavir with 2 NRTIs per the usual standard of care of the investigator in AIDS clinics of Russia

Trial Locations (4)

Irkutsk Regional AIDS Center, Irkutsk

Moscow City AIDS Center of the Moscow Health Department, Moscow

Saint-Petersburg AIDS and Infectious Diseases Center, Saint Petersburg

Samara Region AIDS Center, Samara